FindTrial
Sign In

Tetanus Toxoid Vaccine

BIOLOGICAL8 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Novartis, Epicentre, HIV Vaccine Trials Network, University of Nebraska

Conditions

AstrocytomaGliomaHIV InfectionHIV InfectionsOligodendrogliomaPlasma Cell MyelomaRelapsing Multiple SclerosisTetanus

Phase 1

Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
CompletedNCT02109354
HIV Vaccine Trials NetworkHIV Infection
Start: 2013-06-18End: 2015-02-02Updated: 2019-06-21

Phase 2

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
WithdrawnNCT00008866
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections
Updated: 2021-11-01
Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
TerminatedNCT02700841
University of NebraskaPlasma Cell Myeloma
Start: 2020-01-09End: 2022-12-21Updated: 2024-03-12

Phase 3

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
CompletedNCT01199861
NovartisRelapsing Multiple Sclerosis
Start: 2010-08-31End: 2011-05-31Updated: 2012-06-19

Unknown Phase

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
CompletedNCT00001119
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections
Start: 1999-10-31Target: 288Updated: 2011-03-02
A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
CompletedNCT00000943
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections
End: 2005-11-30Target: 50Updated: 2021-10-29
Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain
CompletedNCT01559597
EpicentreTetanus, Tetanus Vaccine
Start: 2012-11-30End: 2013-03-31Updated: 2013-05-03
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
CompletedNCT02747407
Wake Forest University Health SciencesAstrocytoma, Glioma, Oligodendroglioma
Start: 2016-05-31End: 2021-09-09Updated: 2021-10-29

Related Papers

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
Emerging Microbes & Infections2025-04-071 citations
The Question of HIV Vaccine: Why Is a Solution Not Yet Available?
Journal of Immunology Research2024-01-0112 citations
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.
2020-01-3016 citations
Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa
PLoS ONE2014-11-179 citations